Abstract The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal
stem cells (MSCs) to the sites of tissue damage. Our recent study demonstrated that …

Background: The interaction between stromal cell-derived factor 1 (SDF-1) and its receptor
CXC chemokine receptor 4 (CXCR4) plays an important role in mesenchymal stem cells …

Our previous studies showed that the combination of atorvastatin (ATV) and single injection
of ATV-pretreated mesenchymal stem cells (MSCs)(ATV-MSCs) at 1 week post-acute …

OBJECTIVE: Both atorvastatin and cell-based therapy were reportedly beneficial to
ventricular function after acute myocardial infarction (AMI). In this study, we sought to study …

Background/Aims: To investigate the beneficial effects of atorvastatin added to the cell
therapy with bone marrow-derived mesenchymal stromal cells (BMSCs) in a rabbit model of …

Background Adipose-derived mesenchymal stem cells (ASCs) transplantation is a promising
approach for myocardium repair. Promotion of ASCs migration and survival is the key for …

Background Previous studies reported that Atorvastatin (ATOR) can improve the efficacy of
Mesenchymal stem cells (MSCs) transplantation after acute myocardial infarction (AMI) …

The poor viability of transplanted stem cells hampers their therapeutic efficacy for treatment
of myocardial infarction. The aim of this study was to investigate whether rosuvastatin …

Objective—Widespread death of implanted cells hampers stem cell therapy for acute
myocardial infarction (AMI). Based on the pleiotropic beneficial effects of statins, we …

Background: Widespread death of implanted cells hampers the development of stem cell
therapy for acute myocardial infarction (AMI). Our previous studies indicated that statins can …